More SEC Filings
View Older Stories View Newer Stories-
Form 144 Dayforce, Inc. Filed by: Holdridge Stephen H.
-
Form 4 Parker-Hannifin Corp For: Nov 12 Filed by: Bendali Rachid
-
Form 4 Moleculin Biotech, Inc. For: Nov 12 Filed by: Cermak Elizabeth
-
Form 4 BGC Group, Inc. For: Nov 12 Filed by: MBANEFO ARTHUR U
-
Form 13F-HR DME Capital Management, For: Sep 30
-
Form 4 Cencora, Inc. For: Nov 12 Filed by: Krikorian Lazarus
-
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC
-
Form NT 10-Q iSpecimen Inc. For: Sep 30
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Vestal Point Capital, LP
-
Form 13F-NT THORNWOOD ASSOCIATES For: Sep 30
-
Form 13F-HR Holocene Advisors, LP For: Sep 30
-
Form 13F-HR CLEARFIELD CAPITAL MANAG For: Sep 30
-
Form F-3/A Raytech Holding Ltd
-
Form SCHEDULE 13G Eagle Point Credit Co Filed by: Karpus Management, Inc.
-
Form SCHEDULE 13G/A Nuburu, Inc. Filed by: Esousa Group Holdings LLC
-
Form 13F-NT Solar Projects LLC For: Sep 30
-
Form 13F-HR Ararat Capital Managemen For: Sep 30
-
Form 13F-NT DME Advisors, LP For: Sep 30
-
Form 13F-HR Waterford Advisors, LLC For: Sep 30
-
Form 13F-NT HIGHCREST INVESTORS LLC For: Sep 30
-
Form SCHEDULE 13G/A ENVIRI Corp Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Y-mAbs Therapeutics, Filed by: HBM Healthcare Investments (Cayman) Ltd.
-
Form 5 Octagon XAI CLO Income For: Sep 30 Filed by: Mohr Gretchen Mae
-
Form SCHEDULE 13G/A Propanc Biopharma, Inc. Filed by: Ionic Ventures, LLC
-
Form 4 Moleculin Biotech, Inc. For: Nov 12 Filed by: CANNON MICHAEL D
-
Form SCHEDULE 13G/A Safe Pro Group Inc. Filed by: CITADEL ADVISORS LLC
-
Form 13F-HR 1607 Capital Partners, For: Sep 30
-
Form SCHEDULE 13G Eagle Point Credit Co Filed by: Karpus Management, Inc.
-
Form 13F-NT HILLHOUSE INVESTMENT For: Sep 30
-
Form 6-K Oddity Tech Ltd For: Nov 14
-
Form 13F-HR Euclidean Capital LLC For: Sep 30
-
Form SCHEDULE 13G/A Celcuity Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form 4 Strategy Inc For: Nov 12 Filed by: Shao Wei-Ming
-
Form 4 TRAVELERS COMPANIES, For: Nov 12 Filed by: HEYMAN WILLIAM H
-
Form SCHEDULE 13G/A CASI Pharmaceuticals, Filed by: Foresite Capital Fund VI LP
-
Form 13F-NT ICAHN CAPITAL LP For: Sep 30
-
Form 497 Northern Lights Fund
-
Form 4 Moleculin Biotech, Inc. For: Nov 12 Filed by: Climaco John M
-
Form SCHEDULE 13G/A TOWER SEMICONDUCTOR LTD Filed by: Point72 Asset Management, L.P.
-
Form 13F-HR Alibaba Group Holding For: Sep 30
-
Form NT 10-Q Allied Gaming & Entertai For: Sep 30
-
Form 13F-HR Mork Capital Management, For: Sep 30
-
Form 13F-HR Mink Brook Asset Managem For: Sep 30
-
Form SCHEDULE 13G/A Nukkleus Inc. Filed by: Esousa Group Holdings LLC
-
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
-
Form SCHEDULE 13G Eagle Point Credit Co Filed by: Karpus Management, Inc.
-
Form SCHEDULE 13G/A BIOTRICITY INC. Filed by: Ionic Ventures, LLC
-
Form SCHEDULE 13G iBio, Inc. Filed by: Vestal Point Capital, LP
-
Form SCHEDULE 13G/A Upstream Bio, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
-
Form SCHEDULE 13G/A Bloom Energy Corp Filed by: D. E. SHAW & CO, L.P.
